The $7.65 Million Verdict:
What One Hospital’s Disinfection Failure Actually Cost
A Kansas jury awarded $7.65 million to the family of a Navy veteran who died after contracting a rare bacterial infection following open-heart surgery. The trial centered on contaminated medical devices and a disinfection protocol that failed. Here is what happened — and what every infection preventionist needs to take away from it.
What happened
On April 29, 2026, a Wyandotte County jury awarded $7.65 million in damages to the wife and son of Stephen Nolte — a 71-year-old U.S. Navy veteran and retired electrician who underwent an aortic valve replacement at the University of Kansas Medical Center on March 6, 2019. He developed a Mycobacterium chimaera infection following the procedure and died on July 8, 2020. The jury attributed 88% of the fault to the University of Kansas Hospital Authority and 12% to LivaNova USA Inc., the medtech company that manufactured the heater-cooler device used during his surgery.
The Nolte case is not isolated. According to Infection Control Today, more than two dozen lawsuits have been filed in Wyandotte County District Court against the University of Kansas Hospital Authority and LivaNova, alleging that at least 25 patients contracted M. chimaera infections tied to the devices. Eleven of those patients died.
What is Mycobacterium chimaera — and how did it get inside a patient during heart surgery
Mycobacterium chimaera is a slow-growing nontuberculous mycobacterium (NTM) found naturally in soil and water. Under normal circumstances it poses minimal risk to healthy individuals. During cardiac surgery, it becomes extraordinarily dangerous because of one specific piece of equipment: the heater-cooler device.
Heater-cooler devices are used during cardiopulmonary bypass procedures to regulate patient temperature while connected to heart-lung machines. They contain water tanks with internal pumps. According to Becker’s Cardiology, if not properly sterilized, the contaminated water inside these devices can be aerosolized by exhaust fans and released into the operating room environment — directly into the open chest cavity of a surgical patient.
Latency. M. chimaera is a slow-growing organism. The New South Wales Health authority notes that infections have been diagnosed anywhere from months to up to twelve years after open-heart surgery. Symptoms are non-specific: fatigue, weight loss, persistent cough, fever, nausea, blurred vision. By the time the infection is identified, it has often advanced significantly. Stephen Nolte underwent surgery in March 2019 and died in July 2020 — 16 months later. He was 71.
What the trial revealed about disinfection protocols
The trial focused heavily on cleaning and disinfection practices. Testimony revealed that KU Medical had initially followed LivaNova’s disinfection instructions for the heater-cooler devices. The case examined whether those instructions were adequate, whether the hospital had deviated from them, and whether LivaNova had provided sufficient warning about the aerosolization risk.
The jury’s verdict — 88% fault to the hospital, 12% to the manufacturer — suggests the jury found the primary failure lay in the hospital’s implementation of its disinfection and maintenance protocols, not solely in the device design. That distinction matters enormously for the infection prevention community.
“The verdict places primary responsibility on the institution. A contaminated device that was properly cleaned is a manufacturer defect. A contaminated device that was improperly cleaned is an infection prevention failure.”
The CDC has previously issued health alerts about the risks of NTM infections from heater-cooler devices, and the FDA has published updated guidance for reducing cardiac surgery infection risks associated with LivaNova’s 3T system. The issue is not new. What the KU Medical verdict makes clear is that the legal and financial consequences of protocol failures are now being fully quantified in court.
The KU Medical cases are part of a global outbreak of M. chimaera infections linked to heater-cooler devices — specifically the LivaNova (formerly Sorin) 3T Heater-Cooler System. Contamination has been traced to the manufacturing facility, where the organism entered devices before they left the factory.
Published research in Emerging Infectious Diseases and the Journal of Hospital Infection has documented cases across Europe, North America, and Australia. One Swiss study found that M. chimaera re-emerged in heater-cooler units despite an intensified cleaning and disinfection protocol — underscoring how difficult this organism is to eradicate once established in a water system.
The International Society of Cardiovascular Infectious Diseases has published guidelines for diagnosis, treatment, and prevention. The CDC has published a MMWR report on Kansas and California cases from 2019. The issue has been known at the highest levels of infection prevention for years. And yet the lawsuits continue.
What this means for infection preventionists and hospital administrators
The KU Medical verdict is not primarily a story about one device or one hospital. It is a story about the institutional cost of inadequate device disinfection protocols — and about the legal standard that is now being applied when those protocols fail.
The financial exposure is real and specific: the CDC estimates HAIs cost U.S. hospitals $28–33 billion annually. Central-line bloodstream infections average $45,814 per case. Surgical site infections average $20,785 per case. A single wrongful death verdict tied to a device disinfection failure runs into the millions. The question every hospital administrator should be asking after April 29, 2026 is not whether their protocols are documented — it is whether they are being followed, verified, and audited.
1. Are your device disinfection protocols current? FDA and CDC guidance for heater-cooler devices has been updated multiple times. When did your institution last review its protocol against current guidance?
2. Are your protocols being followed? Testimony at KU Medical focused not just on what the protocol said, but on what actually happened. Rounding, observation, and compliance data are your defense.
3. Are the right disinfectants being used on the right surfaces? The distinction between a cleaner and a disinfectant — between a product with a kill claim and one without — is exactly the kind of detail that surfaces in litigation. EPA registration numbers, contact times, and compatibility documentation matter.
The right disinfection standard for medical devices
For surfaces and equipment that cannot be autoclaved or submerged, the standard is EPA-registered chemical disinfection with validated kill claims and documented contact time compliance. This applies to bed rails, call buttons, monitors, cables, keyboards, and the external surfaces of devices like heater-coolers that interact with the clinical environment.
SONO Disinfecting Wipes (EPA Reg. #6836-340-89018) are formulated specifically for the clinical environment — safe on the plastics, rubber, vinyl, and electronics that medical devices are made of, while delivering hospital-grade disinfection against 47 pathogens including MRSA, VRE, HIV-1, HBV, HCV, and SARS-CoV-2.
Alcohol-free formulation means no degradation of plastic housings, no yellowing of cables, no compromise of adhesive labels — the material compatibility failures that accelerate equipment deterioration and create the surface microcracks where pathogens can shelter. OSHA Bloodborne Pathogen Standard 1910.1030 compliant. Made in the USA.
The institutional lesson from Wyandotte County
Stephen Nolte went to KU Medical for a heart valve replacement and died sixteen months later from a bacterium he encountered in the operating room. His family spent years in litigation. A jury deliberated for three and a half hours before awarding $7.65 million. The University of Kansas Hospital Authority bears 88% of that responsibility.
None of that is a hypothetical. It happened. It will happen again at other institutions where device disinfection protocols are outdated, underfollowed, or inadequately documented. The legal standard for institutional liability in device-associated infection cases is now being drawn by verdicts like this one — and the financial exposure is no longer theoretical.
“The disinfectant on the shelf that was never applied correctly is not a defense. The protocol that was written but not followed is not a defense. The jury is not interested in what the policy said. It is interested in what actually happened to the patient.”
For infection preventionists, the takeaway is straightforward: documented compliance is not paperwork. It is institutional protection. The right disinfectant, applied correctly, to the right surfaces, with verified contact time, creates a chain of evidence that a protocol was followed. The absence of that chain is what a plaintiff’s attorney constructs a case around.
EPA Registration #6836-340-89018 • 47 pathogen kill claims • MRSA, VRE, HIV-1, HBV, HCV, SARS-CoV-2 • 4-minute contact time for bacteria • Alcohol-free • Safe on medical plastics, rubber, vinyl, and electronics • OSHA 1910.1030 compliant • Made in USA • Available through Henry Schein, McKesson, Medline, and major healthcare distributors.
SONO Disinfecting Wipes — EPA registered, equipment-safe, hospital-grade
47 pathogens • EPA Reg. #6836-340-89018 • Alcohol-free • OSHA compliant • Made in USA
Shop 80ct CanisterShop 80ct Soft PackRelated Reading
→ The FibroScan Standard — Why the wipe you use on medical equipment matters more than most realize.
→ The Disinfectant Gap — Why cleaning and disinfecting are not the same thing.
→ MRSA: The Superbug in Plain Sight — The hospital-acquired pathogen most people underestimate.
References & Sources
- Infection Control Today. $7.65 Million Verdict in KU Medical Heater-Cooler Infection Case. April 2026. infectioncontroltoday.com
- Thomas JL. Jury awards $7.65 million in damages in fatal KU Med heart surgery infection case. AOL News, April 29, 2026. aol.com
- Becker’s Cardiology. U of Kansas Hospital faces lawsuits over open-heart surgery infections. beckerscardiology.com
- NSW Health. Mycobacterium chimaera and heater-cooler devices. health.nsw.gov.au
- Schreiber PW, et al. Reemergence of Mycobacterium chimaera in heater-cooler units despite intensified cleaning and disinfection protocol. Emerg Infect Dis. 2016;22:1830–1833.
- Hasse B, et al. International Society of Cardiovascular Infectious Diseases guidelines for M. chimaera infection following cardiac surgery. J Hosp Infect. 2020;104:214–235.
- CDC. HAIs: Reports and Data. Updated January 30, 2026. cdc.gov/healthcare-associated-infections
- SONO Healthcare. SONO Disinfecting Wipes FDS — EPA Reg. #6836-340-89018. sonosupplies.com
